Category: Medicine and Healthcare
Study aims to identify novel blood-based inflammatory markers that can be used to both identify and stratify Parkinson's disease patients
Broadens immunomodulatory peptide portfolio while also expanding route of administration capabilities
Launches preclinical development effort of LBT-3627 as a neuroprotective/repair treatment for Multiple Sclerosis